Peter Yat Ming Woo

12PUBLICATIONS
24CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Central nervous systemCancer therapy (excl. chemotherapy and radiation therapy)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 21, 2026
Outcomes of H3K27M-altered diffuse midline glioma adult Chinese patients and real-world experience with German-sourced ONC201 targeted therapy: A multi-center study in Hong Kong.

|Mar 03, 2026
GITR activation potentiates anti-tumor immunity of tumor-infiltrating lymphocytes expanded from glioblastoma by rescuing exhaustion.

Jiayi Zhou, Yinggui Yang, Ran Ye

|Sep 27, 2025
Spinal Metastasis from Supratentorial Glioblastoma: A Registry-Based Case Series and a Review of the Literature.

Arthur Chak Kai Lau, Desiree Ka-Ka Wong, Justin Chun Him Cheung

|Dec 11, 2024
The impact of timing of temozolomide chemoradiotherapy for newly diagnosed glioblastoma on patient overall survival: A multicenter retrospective study.

Arthur C K Lau, Brandon L H Chan, Carly S K Yeung

|Oct 14, 2022
Development of the SAFETEA Scores for Predicting Risks of Complications of Preventive Endovascular or Microneurosurgical Intracranial Aneurysm Occlusion.

Annemijn M Algra, Jacoba P Greving, Jordi de Winkel

|Feb 12, 2021
Radiotherapy-induced glioblastoma: distinct differences in overall survival, tumor location, pMGMT methylation and primary tumor epidemiology in Hong Kong chinese patients.

Peter Y M Woo, Jennifer W Y Lee, Sandy W Lam

Pageof 2

Frequent Collaborators

2 joint publications

Arthur Chak Kai Lau

1 joint publications

Annemijn M Algra

1 joint publications

Jacoba P Greving

1 joint publications

Jordi de Winkel